Clinicore
FRG76 5mg – Research Vial
FRG76 5mg – Research Vial
Couldn't load pickup availability
FRG76 5mg Research Peptide Vial
Lyophilised FRG76 supplied as a 5mg vial for controlled in-vitro research workflows.
CLINICORE FRG76 5mg research peptide is supplied as a lyophilised solid in a single vial format for laboratory and analytical workflows. This FRG76 peptide vial is intended for non-clinical in-vitro research environments where consistent presentation and documented handling are required.
Overview
FRG76, also referred to as HGH Fragment 176-191, is a specialised research peptide used in controlled in-vitro studies relating to metabolism and endocrinology under non-clinical laboratory conditions.
Handling and solubility
This section provides FRG76 handling guidance for laboratory workflows. Handle using appropriate laboratory PPE and standard laboratory safety procedures.
Due to the presence of hydrophobic amino acid sequences, this peptide may appear cloudy after reconstitution. This is normal and does not affect research quality.
Storage guidelines
These FRG76 storage guidelines apply to lyophilised research peptides. Follow the CLINICORE reconstitution and storage instructions supplied on the website to maintain stability.
Intended use
This FRG76 research peptide is supplied strictly for laboratory research use only. It is not for human or veterinary use and is not approved for clinical, diagnostic, or therapeutic applications.
CLINICORE quality and assurance
CLINICORE Peptides manufactures research materials through controlled synthesis processes designed to deliver high purity and batch consistency. Each FRG76 batch undergoes internal identity and appearance checks prior to release.
If additional documentation is required for internal QC or research records, please contact the CLINICORE team prior to use so we can advise what information may be available.
Share
